ByCus Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

ByCus Therapeutics General Information

Description

Developer of biotechnology products designed to provide sustainable living to individuals. The company develops drug substances and products that support a patient-first approach, enhancing the standard of medical care, enabling users to increase their affordability while improving patient care.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • University of Hyderabad, Ouh Bio-nest School Of Lifesciences
  • Suite Number 13, Gachibowli
  • Hyderabad, Telangana 500046
  • India
Primary Industry
Biotechnology
Corporate Office
  • University of Hyderabad, Ouh Bio-nest School Of Lifesciences
  • Suite Number 13, Gachibowli
  • Hyderabad, Telangana 500046
  • India

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ByCus Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 01-Apr-2023 Completed Generating Revenue
1. Accelerator/Incubator 16-Mar-2021 Completed Generating Revenue
To view ByCus Therapeutics’s complete valuation and funding history, request access »

ByCus Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
IKP Knowledge Park Accelerator/Incubator Minority
ASPIRE-BioNEST Accelerator/Incubator Minority
To view ByCus Therapeutics’s complete investors history, request access »

ByCus Therapeutics FAQs

  • When was ByCus Therapeutics founded?

    ByCus Therapeutics was founded in 2020.

  • Where is ByCus Therapeutics headquartered?

    ByCus Therapeutics is headquartered in Hyderabad, India.

  • What industry is ByCus Therapeutics in?

    ByCus Therapeutics’s primary industry is Biotechnology.

  • Is ByCus Therapeutics a private or public company?

    ByCus Therapeutics is a Private company.

  • What is ByCus Therapeutics’s current revenue?

    The current revenue for ByCus Therapeutics is .

  • Who are ByCus Therapeutics’s investors?

    IKP Knowledge Park and ASPIRE-BioNEST have invested in ByCus Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process